Beximco Pharmaceuticals Ltd. GDR Stock
The Beximco Pharmaceuticals Ltd. GDR price is unchanged compared to yesterday.
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 0.980% | 0.000% | 19.767% | 14.955% | 3.831% | -47.980% |
| Eledon Pharmaceuticals Inc. | 5.030% | 13.939% | 1.622% | -53.000% | 46.875% | -21.667% | -85.970% |
| SELLAS Life Sciences Group Inc | 9.440% | 30.470% | 11.342% | 264.583% | 41.975% | 146.102% | -44.984% |
| Grifols S.A. ADR | -3.210% | -2.581% | 0.000% | 8.633% | -0.658% | -12.209% | -42.243% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%